Wildi S M, Fickling W E, Day T A, Cunningham C D, Schmulewitz N, Varadarajulu S, Roberts S S, Ferguson B, Hoffman B J, Hawes R H, Wallace M B
Digestive Disease Center, Medical University of South Carolina, Charleston, SC, USA.
Endoscopy. 2004 Jul;36(7):624-30. doi: 10.1055/s-2004-814521.
Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) is a minimally invasive and highly accurate method of detecting mediastinal lymph-node metastases in gastrointestinal and lung cancer. Little information is available regarding the use of EUS-FNA to stage tumors in the head and neck region. This study reports experience with EUS in the diagnosis and staging of these tumors and their mediastinal spread.
The records of patients who underwent EUS for diagnosis and/or staging of head and neck tumors were reviewed. Referral criteria were suspected invasion of the esophagus by a lower-neck mass on cervical computed tomography (CT) or magnetic resonance imaging (MRI), or mediastinal lymphadenopathy > 10 mm on a chest CT.
Thirty-two patients (23 men, nine women; mean age 65 years, range 44 - 80) were referred and underwent 35 EUS examinations. In one patient, EUS was not possible due to a benign esophageal stricture. In 17 patients with suspected esophageal invasion on CT scans, EUS demonstrated invasion of the esophagus in four cases and of the pleura in one; 12 tumors showed no visible invasion of adjacent structures. The other 17 examinations were carried out for suspected mediastinal metastatic disease. In eight cases, EUS-FNA confirmed metastatic disease, whereas only benign changes were shown in the other nine cases. EUS-FNA also provided the first tissue diagnosis in two primary tumors and identified malignancy in one patient with no CT suspicion of positive mediastinal lymph nodes. EUS avoided the need for more invasive investigations in all patients with mediastinal lymphadenopathy, and it changed the management in 12 of the 17 patients (71 %) with suspected esophageal invasion and in eight of the 17 patients (47 %) with suspected mediastinal disease.
EUS with FNA provides a viable approach to the diagnosis and staging of tumors in the head and neck region when there is a suggestion of esophageal invasion on CT or MRI, or enlarged mediastinal lymph nodes. EUS with FNA may avoid the need for mediastinoscopy or other more invasive techniques for staging of these neoplasms.
内镜超声引导下细针穿刺活检(EUS-FNA)是一种微创且高度准确的检测胃肠道和肺癌纵隔淋巴结转移的方法。关于使用EUS-FNA对头颈部肿瘤进行分期的信息较少。本研究报告了EUS在这些肿瘤的诊断、分期及其纵隔扩散方面的经验。
回顾了接受EUS用于头颈部肿瘤诊断和/或分期的患者记录。转诊标准为颈部计算机断层扫描(CT)或磁共振成像(MRI)显示下颈部肿块疑似侵犯食管,或胸部CT显示纵隔淋巴结肿大>10mm。
32例患者(23例男性,9例女性;平均年龄65岁,范围44-80岁)被转诊并接受了35次EUS检查。1例患者因良性食管狭窄无法进行EUS检查。17例CT扫描疑似食管侵犯的患者中,EUS显示4例食管侵犯,1例胸膜侵犯;12例肿瘤未显示对相邻结构的可见侵犯。另外17次检查是针对疑似纵隔转移疾病进行的。8例中,EUS-FNA证实为转移性疾病,而其他9例仅显示良性改变。EUS-FNA还为2例原发性肿瘤提供了首次组织诊断,并在1例CT未怀疑纵隔淋巴结阳性的患者中确定为恶性。EUS避免了所有纵隔淋巴结肿大患者进行更具侵入性检查的必要性,并且改变了17例疑似食管侵犯患者中12例(71%)以及17例疑似纵隔疾病患者中8例(47%)的治疗方案。
当CT或MRI提示食管侵犯或纵隔淋巴结肿大时,EUS联合FNA为头颈部肿瘤的诊断和分期提供了一种可行的方法。EUS联合FNA可能避免对这些肿瘤进行纵隔镜检查或其他更具侵入性的分期技术。